Allogeneic Anti-CD19 CAR-T

· Shanghai Zhongshan Hospital

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Allogeneic Anti-CD19 CAR-T, covering 2025-08-19 to 2025-08-19. Get the full timeline:

Most recent: Clinical Trial Update: Allogeneic Anti-CD19 CAR-T for Refractory Graves' Disease [EARLY_Phase 1]